NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

It's my understand that there will be *a* BMY/NWBO trial at UCLA, because Prins talked about it. However as I had pointed out, that does not preclude our partnering with MD Anderson on one of the other of the 3 trials, possibly with other than the two BP partners mentioned by Prins, although the 'formula' given by NWBO doesn't preclude any possible matrix of [partners X indication]. E.g. their interesting wording would allow for a second trial with BMY at MD Anderson but for a different cancer than the UCLA trial. At least that is not disallowed according to the many ways we can parse or interpret the NWBO statement, as I said. Because BMY+MD Anderson is a different 'set of partners' than BMY+UCLA. Do you disagree? As a reminder here is exactly what NWBO said about it:

The Company has reached conceptual agreement with three different sets of parties, in regard to three different combination treatments, for three different cancers in three different Phase II trials. These involve leading participants in the immunotherapy field.